5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Update: 2024-11-25

Description

Dr Seth Wander from Massachusetts General Hospital in Boston discusses recent developments with oral selective estrogen receptor degraders for ER-positive metastatic breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Myelofibrosis

2025-01-1301:59:14

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer

2025-01-1002:00:59

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia

2025-01-0801:26:59

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia

2025-01-0601:58:50

Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer

2025-01-0302:00:36

Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer

2024-12-2301:31:28

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma

2024-12-2001:57:10

What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia

2024-12-1801:57:07

Cases from the Community: Integrating New Research Findings into Current Practice — Colorectal and Gastroesophageal Cancers

2024-12-1849:10

Cases from the Community: Integrating New Research Findings into Current Practice — Hepatobiliary Cancers

2024-12-1855:49

Cases from the Community: Integrating New Research Findings into Current Practice — Gynecologic Cancers

2024-12-1746:41

Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis

2024-12-1751:43

Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes

2024-12-1351:44

Cases from the Community: Integrating New Research Findings into Current Practice — Lung Cancer

2024-12-1348:03

5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2

2024-12-1311:58

Meet The Professor: Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review

2024-12-1058:47

Exploring the Current Management Paradigm for Patients with Metastatic Triple-Negative Breast Cancer

2024-12-0459:42

Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria

2024-12-0301:46:37

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma

2024-11-2652:45

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

2024-11-2510:55

00:00

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

#box-pro-ellipsis-173695819057820{-webkit-line-clamp:2;}5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer

Research To Practice

5-Minute Journal Club Issue 1 with Dr Seth Wander: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer